| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Conaway Samuel is a Director at GUTS. Recent filings cover 1 purchase and 0 sales. Those positions are worth an estimated $10K at current prices.
Conaway Samuel's largest disclosed position is in GUTS as Director, worth about $10K. Net of sales, the recent Form 4 record there shows accumulation of 8,550 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 13, 2025 | GUTS Fractyl Health, Inc. | Director | Buy | 8,550 | $1.17 | $9,964.17 | New | +88.4% | -61.3% |